TrialThe oncologist2016

A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel.

Oleg Gladkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.